Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamaz increased its share in heavy truck sales

5/19/25 KMAZ

The court partially satisfied the claim of Aeroflot to Yakovlev for $84.8 million.

5/19/25 AFLT

The Board of Directors of Abrau-Durso will recommend a dividend of 5.01 per share

5/19/25 ABRD

Board of Directors of Crystal recommended that dividends be paid for 2024

5/19/25 KLVZ

Delimobil changed its CEO

5/19/25 DELI

Softline's profit tripled in Q1 2025

5/19/25 SOFL

There is a real wine cultural revolution going on in Russia

5/19/25 ABRD

Lenenergo reported for 3 months of 2025 by RAS

5/16/25 LSNG

M.video reported for 3 months of 2025 by RAS

5/16/25 MVID

Uralsib reported for 3 months of 2025 by RAS

5/16/25 USBN